| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.007 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |